Cargando…
Risk of Budd-Chiari Syndrome Associated with Factor V Leiden and G20210A Prothrombin Mutation: A Meta-Analysis
BACKGROUND: Various studies have demonstrated that factor V Leiden (FVL) and G20210A prothrombin mutation contribute to the risk of Budd-Chiari syndrome (BCS), while other studies provided conflicting findings. In order to derive more precise estimations of the relationships, a meta-analysis was per...
Autores principales: | Zhang, Peijin, Zhang, Jing, Sun, Guixiang, Gao, Xiuyin, Wang, Hui, Yan, Wenjun, Xu, Hao, Zu, Maoheng, Ma, He, Wang, Wei, Lu, Zhaojun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995749/ https://www.ncbi.nlm.nih.gov/pubmed/24755609 http://dx.doi.org/10.1371/journal.pone.0095719 |
Ejemplares similares
-
Review of Budd-Chiari Syndrome
por: Zu, Maoheng, et al.
Publicado: (2020) -
Factor V Leiden G1691A and Prothrombin Gene G20210A Mutations on Pregnancy Outcome
por: Padda, Jaskamal, et al.
Publicado: (2021) -
Association between JAK2 rs4495487 Polymorphism and Risk of Budd-Chiari Syndrome in China
por: Zhang, Peijin, et al.
Publicado: (2015) -
Experts consensus on Chinese nomenclature of Budd-Chiari syndrome
por: Zu, Maoheng, et al.
Publicado: (2021) -
Thrombophilic Genetic Factors PAI-1, MTHFRC677T, V Leiden 506Q, and Prothrombin 20210A in Noncirrhotic Portal Vein Thrombosis and Budd-Chiari Syndrome in a Caucasian Population
por: D'Amico, Mario, et al.
Publicado: (2013)